a developer of cell based immune therapeutics and vaccines for cancer treatment
Industry Biotechnology
A.I.dvisor tells us that MRKR and CGTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MRKR and CGTX's prices will move in lockstep.
Ticker / NAME | Correlation To MRKR | 1D Price Change % | ||
---|---|---|---|---|
MRKR | 100% | +17.68% | ||
CGTX - MRKR | 30% Poorly correlated | +0.86% | ||
UNCY - MRKR | 26% Poorly correlated | -0.07% | ||
ADTX - MRKR | 25% Poorly correlated | -13.43% | ||
VERV - MRKR | 25% Poorly correlated | +3.70% | ||
TFFP - MRKR | 24% Poorly correlated | N/A | ||
More |